Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome — Stella

Home/Eisenmenger Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Eisenmenger Syndrome trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Brazil

Antonio Augusto Barbosa Lopes, São Paulo

Key details

Sponsor

University of Sao Paulo General Hospital

Collaborators

InCor Heart Institute

Enrollment target

~48 participants

Started

June 2022

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

10 Years – 80 Years

Last updated December 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.